{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T21:20:24Z","timestamp":1788384024081,"version":"build-2803163510"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T00:00:00Z","timestamp":1590624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T00:00:00Z","timestamp":1590624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004337","name":"St. George's University of London","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004337","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Community Genet"],"published-print":{"date-parts":[[2020,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Pharmacogenomics describes interpatient genetic variability in drug responses. Information based on whole genome sequencing will soon open up the field of pharmacogenomics and facilitate the use of genomic information relating to drug metabolism and drug responses. We undertook a qualitative study, aiming to explore the potential barriers, opportunities and challenges facing the implementation of pharmacogenomics into primary care. Semi-structured interviews were undertaken with 18 clinical participants (16 GPs and 2 other clinicians). All interviews were recorded and transcribed verbatim. Using a thematic analysis approach, data items were coded, ordered and themes constructed. Most participants were aged 55\u201360\u00a0years and worked as part-time clinical GPs with other clearly defined roles. The emerging themes covered several areas of concern, including the following: the utility of pharmacogenomics and the value of introducing such testing into primary care; how to educate the primary care workforce and \u2018mainstream\u2019 pharmacogenomics; the ethical, legal and social aspects of pharmacogenomics and its impact on patients; and potential impacts on the healthcare system particularly around economics and informatics. Most participants had concerns about pharmacogenomics and felt that there were a number of barriers and challenges to its implementation into routine primary care. Most striking were their concerns around the cost-effectiveness of using pharmacogenomics in primary care. At the same time most recognised the increasing availability of direct-to-consumer testing, and felt that this would drive the need to understand the ethical and social implications of using genomic information in primary care. This study has raised important issues that need to be considered when planning the implementation of pharmacogenomics into clinical practice. Prior to the implementation of genomic testing into day-to-day practice in UK primary care, it is important that considerations around education, cost-effectiveness and informatics are addressed, as well as the impact on patients.<\/jats:p>","DOI":"10.1007\/s12687-020-00468-2","type":"journal-article","created":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T17:10:08Z","timestamp":1590685808000},"page":"269-277","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["The implementation of pharmacogenomics into UK general practice: a qualitative study exploring barriers, challenges and opportunities"],"prefix":"10.1007","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9673-9675","authenticated-orcid":false,"given":"I.","family":"Rafi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Crinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Dawes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Rafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Pirmohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. M.","family":"Walter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,28]]},"reference":[{"key":"468_CR1","unstructured":"Genomics England (n.d.) https:\/\/www.genomicsengland.co.uk\/"},{"key":"468_CR2","unstructured":"HEE Genomics Programme: Engaging Primary Care (n.d.) https:\/\/www.genomicseducation.hee.nhs.uk\/images\/pdf\/Engaging%20Primary%20Care_June%202016.pdf"},{"issue":"665","key":"468_CR3","doi-asserted-by":"publisher","first-page":"540","DOI":"10.3399\/bjgp17X693533","volume":"67","author":"SC Hillman","year":"2017","unstructured":"Hillman SC, Dale J (2017) Genomics in general practice: generation genome. Br J Gen Pract 67(665):540\u2013541. https:\/\/doi.org\/10.3399\/bjgp17X693533","journal-title":"Br J Gen Pract"},{"issue":"655","key":"468_CR4","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3399\/bjgp17X688945","volume":"67","author":"J Hayward","year":"2017","unstructured":"Hayward J, Bishop M, Rafi I, Davison V (2017) Genomics in routine clinical care: what does this mean for primary care? Br J Gen Pract 67(655):58\u201359. https:\/\/doi.org\/10.3399\/bjgp17X688945","journal-title":"Br J Gen Pract"},{"key":"468_CR5","doi-asserted-by":"publisher","unstructured":"Walter FM, Emery J and Burton H. 2014. Chronic disease prevention in primary care: how and when will genomics impact? Br J Gen Pract 64 (624): 331\u2013332. https:\/\/doi.org\/10.3399\/bjgp14X680401","DOI":"10.3399\/bjgp14X680401"},{"key":"468_CR6","doi-asserted-by":"publisher","unstructured":"Bouwman L, Molder H, Hiddink G, (2009) Patients, evidence and genes: an exploration of GPs\u2019 perspectives on gene-based personalized nutrition advice, in: Family Practice. doi:https:\/\/doi.org\/10.1093\/fampra\/cmn067","DOI":"10.1093\/fampra\/cmn067"},{"key":"468_CR7","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1111\/cge.12626","volume":"89","author":"KD Christensen","year":"2016","unstructured":"Christensen KD, Vassy JL, Jamal L, Lehmann LS, Slashinski MJ, Perry DL, Robinson JO, Blumenthal-Barby J, Feuerman LZ, Murray MF, Green RC, Mcguire AL (2016) Are physicians prepared for whole genome sequencing? A qualitative analysis. Clin Genet 89:228\u2013234. https:\/\/doi.org\/10.1111\/cge.12626","journal-title":"Clin Genet"},{"issue":"9","key":"468_CR8","first-page":"545","volume":"38","author":"CL Ventola","year":"2013","unstructured":"Ventola CL (2013) Role of pharmacogenomic biomarkers in predicting and improving drug response: part 1: the clinical significance of pharmacogenetic variants. Pharmacy and Therapeutics 38(9):545\u2013560","journal-title":"Pharmacy and Therapeutics"},{"key":"468_CR9","unstructured":"Adverse Drug reactions- summary (n.d.) https:\/\/cks.nice.org.uk\/adverse-drug-reactions#!topicsummary. Accessed 2\/7\/2017"},{"issue":"613","key":"468_CR10","doi-asserted-by":"publisher","first-page":"e543","DOI":"10.3399\/bjgp13X670679","volume":"63","author":"AJ Avery","year":"2013","unstructured":"Avery AJ, Ghaleb M, Barber N, Dean Franklin B, Armstrong SJ, Serumaga B, Dhillon S, Freyer A, Howard R, Talabi O, Mehta RL (2013) The prevalence and nature of prescribing and monitoring errors in English general practice: a retrospective case note review. Br J Gen Pract 63(613):e543\u2013e553. https:\/\/doi.org\/10.3399\/bjgp13X670679","journal-title":"Br J Gen Pract"},{"key":"468_CR11","unstructured":"Professor Bill Newman (2017) President of the British Society of Human Genetics. Presentation on Pharmacogenetics to Genomics England. June 2017. Personnel communication"},{"key":"468_CR12","first-page":"588","volume":"92","author":"KL Chang","year":"2015","unstructured":"Chang KL, Weitzel K, Schmidt S (2015) Pharmacogenetics: using genetic information to guide drug therapy. Am Fam Physician 92:588\u2013594","journal-title":"Am Fam Physician"},{"key":"468_CR13","doi-asserted-by":"crossref","unstructured":"Takahashi PY, Ryu, E Pathak J et al. 2017. Increased risk of hospitalisation for ultrarapid metabolisers of cytochrome 450 2D6. Pharmacogenomics and Personalised Medicine V10:39-47. *","DOI":"10.2147\/PGPM.S114211"},{"key":"468_CR14","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1056\/NEJMoa1311386","volume":"369","author":"M Pirmohamed","year":"2013","unstructured":"Pirmohamed M, Burnside G, Eriksson N, Jorgensen AL, Toh CH, Nicholson T, Kesteven P, Christersson C, Wahlstr\u00f6m B, Stafberg C, Zhang JE, Leathart JB, Kohnke H, Maitland-van der Zee AH, Williamson PR, Daly AK, Avery P, Kamali F, Wadelius M (2013) A randomized trial of genotype-guided dosing of warfarin. N Engl J Med 369:2294\u20132303","journal-title":"N Engl J Med"},{"key":"468_CR15","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1378\/chest.14-2947","volume":"148","author":"K Dahal","year":"2015","unstructured":"Dahal K, Sharma SP, Fung E, Lee J, Moore JH, Unterborn JN, Williams SM (2015) Meta-analysis of randomized controlled trials of genotype-guided vs standard dosing of warfarin. Chest 148:701\u2013710","journal-title":"Chest"},{"key":"468_CR16","unstructured":"Kendrick, E., Daly, A., Kamali, F., Hanley J., Sheth H., Curtis A., and Burn J. (2017) Implementation of genotype guided warfarin dosing in the North East. http:\/\/www.ahsn-nenc.org.uk\/wp-content\/uploads\/2014\/12\/177-John-Burn-and-Elizabeth-Kendrick.pdf. Accessed 22\/07\/2017"},{"key":"468_CR17","unstructured":"The Clinical Pharmacogenetics Implementation Consortium (n.d.) (https:\/\/cpicpgx.org\/guidelines). Accessed 07\/07\/201"},{"key":"468_CR18","unstructured":"Pharmacogenomics Knowledge Base resource (2017) (https:\/\/www.pharmgkb.org\/). Accessed 07\/07\/2017"},{"key":"468_CR19","unstructured":"Ritchie J., Lewis J., Nicholls C., Ormston R. (2003) Qualitative research practice. Second edition. Sage"},{"issue":"10","key":"468_CR20","first-page":"e626","volume":"62","author":"JC Carroll","year":"2016","unstructured":"Carroll JC, Makuwaza T, Manca DP, Sopcak N, Permaul JA, O'Brien MA, Heisey R, Eisenhauer EA, Easley J, Krzyzanowska MK, Miedema B, Pruthi S, Sawka C, Schneider N, Sussman J, Urquhart R, Versaevel C, Grunfeld E (2016) Primary care providers' experiences with and perceptions of personalized genomic medicine. Canadian Family Physician M\u00e9decin De Famille Canadien 62(10):e626\u2013e635","journal-title":"Canadian Family Physician M\u00e9decin De Famille Canadien"},{"issue":"5","key":"468_CR21","doi-asserted-by":"publisher","first-page":"477","DOI":"10.2217\/pme.14.36","volume":"11","author":"G Bartlett","year":"2014","unstructured":"Bartlett G, Rahimzadeh V, Longo C, Orlando LA, Dawes M, Lachaine J, Bochud M, Paccaud F, Bergman H, Crimi L, Issa AM (2014) The future of genomic testing in primary care: the changing face of personalized medicine. Personalized Medicine 11(5):477\u2013486","journal-title":"Personalized Medicine"},{"key":"468_CR22","doi-asserted-by":"publisher","first-page":"c6624","DOI":"10.1136\/bmj.c6624","volume":"341","author":"H-C Julia","year":"2010","unstructured":"Julia H-C, Carol C, John R, Peter B (2010) Derivation, validation, and evaluation of a new QRISK model to estimate lifetime risk of cardiovascular disease: cohort study using QResearch database. BMJ 341:c6624","journal-title":"BMJ"},{"issue":"4","key":"468_CR23","first-page":"e11613","volume":"12","author":"A Baroncini","year":"2016","unstructured":"Baroncini A, Calabrese O, Colotto M et al (2016) Knowledge and attitude of general practitioners towards direct-to-consumer genomic tests: a survey conducted in Italy. Epidemiol Biostat Public Health 12(4):e11613\u2013e11617","journal-title":"Epidemiol Biostat Public Health"},{"key":"468_CR24","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3399\/bjgp09X395021","volume":"59","author":"I Rafi","year":"2009","unstructured":"Rafi I, Qureshi N, Lucassen A, Modell M, Elmslie F, Kai J, Kirk M, Starey N, Goff S, Brennan P, Hodgson S (2009) \u201cOver-the-counter\u201d genetic testing: what does it really mean for primary care? Br J Gen Pract 59:283\u2013287","journal-title":"Br J Gen Pract"},{"key":"468_CR25","doi-asserted-by":"publisher","first-page":"683","DOI":"10.2217\/pme.12.80","volume":"9","author":"BA Bernhardt","year":"2012","unstructured":"Bernhardt BA, Zayac C, Gordon ES, Wawak L, Pyeritz RE, Gollust SE (2012) Incorporating direct-to-consumer genomic information into patient care: attitudes and experiences of primary care physicians. Personalized Medicine 9:683\u2013692. https:\/\/doi.org\/10.2217\/pme.12.80","journal-title":"Personalized Medicine"},{"key":"468_CR26","first-page":"198","volume":"21","author":"G Bartlett","year":"2012","unstructured":"Bartlett G, Dawes M, Nguyen Q, Phillips MS (2012) Is primary care ready for pharmacogenomics? A feasibility study of warfarin Pharmacogenomic testing in a family medicine clinic. Pharmacoepidemiol Drug Saf 21:198","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"8","key":"468_CR27","doi-asserted-by":"publisher","first-page":"513","DOI":"10.7326\/M15-0995","volume":"164","author":"CH van der Wouden","year":"2016","unstructured":"van der Wouden CH, Carere DA, Maitland-van der Zee AH, Ruffin MT IV, Roberts JS, Green RC, for the Impact of Personal Genomics Study Group\u2020 (2016) Consumer perceptions of interactions with primary care providers after direct-to-consumer personal genomic testing. Ann Intern Med 164(8):513\u2013522","journal-title":"Ann Intern Med"},{"key":"468_CR28","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s12687-017-0296-6","volume":"8","author":"M Paneque","year":"2017","unstructured":"Paneque M, Cornel MC, Curtisova V, Houwink E, Jackson L, Kent A, Lunt P, Macek M, Stefansdottir V, Turchetti D, Skirton H (2017) Implementing genetic education in primary care: the gen-equip programme. Journal of Community Genetics 8:147\u2013150","journal-title":"Journal of Community Genetics"},{"key":"468_CR29","doi-asserted-by":"publisher","unstructured":"Houwink EJF, Muijtjens AMM, Van Teeffelen SR, Henneman L, Rethans JJ, Jacobi F, Van Der Jagt L, Stirbu I, Van Luijk SJ, Stumpel CTRM, Meijers-Heijboer HE, Van Der Vleuten C, Cornel MC, Dinant GJ (2015) Effect of comprehensive oncogenetics training interventions for general practitioners, evaluated at multiple performance levels. PLoS ONE 10. https:\/\/doi.org\/10.1371\/journal.pone.0122648","DOI":"10.1371\/journal.pone.0122648"},{"key":"468_CR30","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/nhs.12304","volume":"19","author":"LC Lopes-Junior","year":"2017","unstructured":"Lopes-Junior LC, Carvalho Junior PM, de Faria Ferraz VE, Nascimento LC, Van Riper M, Floria-Santos M (2017) Genetic education, knowledge and experiences between nurses and physicians in primary care in Brazil: a cross-sectional study. Nurs Health Sci 19:66\u201374. https:\/\/doi.org\/10.1111\/nhs.12304","journal-title":"Nurs Health Sci"},{"issue":"7","key":"468_CR31","doi-asserted-by":"publisher","first-page":"145","DOI":"10.2147\/PGPM.S63715","volume":"2014","author":"KA Johansen Taber","year":"2014","unstructured":"Johansen Taber KA, Dikinson BD (2014) Pharmacogenomics knowledge gaps and educational knowledge among physicians in selected specialities. Pharmacogenomics and Personalised Medicine 2014(7):145\u2013162","journal-title":"Pharmacogenomics and Personalised Medicine"},{"key":"468_CR32","first-page":"428","volume":"43","author":"G Blashki","year":"2014","unstructured":"Blashki G, Metcalfe S, Emery J (2014) Genetics in general practice. Aust Fam Physician 43:428\u2013431","journal-title":"Aust Fam Physician"},{"key":"468_CR33","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.jbi.2015.04.011","volume":"55","author":"CL Overby","year":"2015","unstructured":"Overby CL, Devine EB, Abernethy N, McCune JS, Tarczy-Hornoch P (2015) Making pharmacogenomic-based prescribing alerts more effective: a scenario-based pilot study with physicians. J Biomed Inform 55:249\u2013259. https:\/\/doi.org\/10.1016\/j.jbi.2015.04.011","journal-title":"J Biomed Inform"},{"key":"468_CR34","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2217\/pme.14.68","volume":"12","author":"JL Vassy","year":"2017","unstructured":"Vassy JL, Christensen KD, Slahinski MJ, Lautenbach DM, Raghavan S, Robinson JO, Blumenthal-Barby J, Zausmer Feuerman L, Soleymani Lehmann L, Murray MF, Green RC, McGuireOliver AL (2017) \u201cSomeday it will be the norm\u201d: physician perspectives on the utility of genome sequencing for patient care in the MedSeq project. Personalized Medicine 12:23\u201332. https:\/\/doi.org\/10.2217\/pme.14.68","journal-title":"Personalized Medicine"},{"key":"468_CR35","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/jhg.2015.15","volume":"61","author":"A Wauters","year":"2016","unstructured":"Wauters A, Van Hoyweghen I (2016) Global trends on fears and concerns of genetic discrimination: a systematic literature review. J Hum Genet 61:275\u2013282. https:\/\/doi.org\/10.1038\/jhg.2015.15","journal-title":"J Hum Genet"},{"key":"468_CR36","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12920-016-0186-5","volume":"9","author":"SG Nicholls","year":"2016","unstructured":"Nicholls SG, Etchegary H, Carroll JC, Castle D, Lemyre L, Potter BK, Craigie S, Wilson BJ (2016) Attitudes to incorporating genomic risk assessments into population screening programs: the importance of purpose, context and deliberation. BMC Med Genet 9:25. https:\/\/doi.org\/10.1186\/s12920-016-0186-5","journal-title":"BMC Med Genet"},{"key":"468_CR37","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1037\/hea0000177","volume":"34","author":"KA Kaphingst","year":"2015","unstructured":"Kaphingst KA, Stafford JD, McGowan LD, Seo J, Lachance CR, Goodman MS (2015) Effects of racial and ethnic group and health literacy on responses to genomic risk information in a medically underserved population. Health Psychol 34:101\u2013110. https:\/\/doi.org\/10.1037\/hea0000177","journal-title":"Health Psychol"},{"key":"468_CR38","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/gim.2012.157","volume":"15","author":"TA Manolio","year":"2013","unstructured":"Manolio TA, Chisholm RL, Ozenberger B, Roden DM, Williams MS, Wilson R, Bick D, Bottinger EP, Brilliant MH, Eng C, Frazer KA, Korf B, Ledbetter DH, Lupski JR, Marsh C, Mrazek D, Murray MF, O\u2019Donnell PH, Rader DJ, Relling MV, Shuldiner AR, Valle D, Weinshilboum R, Green ED, Ginsburg GS (2013) Implementing genomic medicine in the clinic: the future is here. Genetics in Medicine 15:258\u2013267. https:\/\/doi.org\/10.1038\/gim.2012.157","journal-title":"Genetics in Medicine"},{"key":"468_CR39","doi-asserted-by":"crossref","unstructured":"Saul RA et al. (2017) Survey of family history taking and genetic testing in pediatric practice. Journal of Community Genetics, pp1\u20137","DOI":"10.1007\/s12687-016-0291-3"},{"key":"468_CR40","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12920-016-0183-8","volume":"9","author":"S McGrath","year":"2016","unstructured":"McGrath S, Ghersi D (2016) Building towards precision medicine: empowering medical professionals for the next revolution. BMC Med Genet 9:23. https:\/\/doi.org\/10.1186\/s12920-016-0183-8","journal-title":"BMC Med Genet"},{"issue":"5","key":"468_CR41","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1002\/2327-6924.12237","volume":"27","author":"KS Brennan","year":"2015","unstructured":"Brennan KS (2015) Clinical implications of pharmacogenetic and microarray testing for advanced practice nurses. J Am Assoc Nurse Pract 27(5):246\u2013255. https:\/\/doi.org\/10.1002\/2327-6924.12237","journal-title":"J Am Assoc Nurse Pract"},{"key":"468_CR42","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/s11096-006-9029-3","volume":"28","author":"JP Clemerson","year":"2006","unstructured":"Clemerson JP, Payne K, Bissell P, Anderson C (2006, June) Pharmacogenetics, the next challenge for pharmacy? Pharm World Sci 28:126\u2013130. https:\/\/doi.org\/10.1007\/s11096-006-9029-3","journal-title":"Pharm World Sci"},{"issue":"15","key":"468_CR43","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.2217\/pgs-2016-0077","volume":"17","author":"SB Haga","year":"2016","unstructured":"Haga SB, Mills R, Moaddeb J, Allen Lapointe N, Cho A, Ginsburg GS (2016) Patient experiences with pharmacogenetic testing in a primary care setting. Pharmacogenomics 17(15):1629\u20131636","journal-title":"Pharmacogenomics"},{"issue":"662","key":"468_CR44","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3399\/bjgp17X692189","volume":"67","author":"D Swinglehurst","year":"2017","unstructured":"Swinglehurst D, Fudge N (2017) The polypharmacy challenge: time for a new script? The British journal of general practice : the journal of the Royal College of General Practitioners 67(662):388\u2013389","journal-title":"The British journal of general practice : the journal of the Royal College of General Practitioners"},{"key":"468_CR45","unstructured":"Genomics and Therapeutics (2017) page 58. The Chief Medical Officer Annual Report- Generation Genomics. https:\/\/www.gov.uk\/government\/publications\/chief-medical-officer-annual-report-2016-generation-genome. Accessed 29\/07\/2017"}],"container-title":["Journal of Community Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12687-020-00468-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12687-020-00468-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12687-020-00468-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T20:00:14Z","timestamp":1622145614000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12687-020-00468-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,28]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["468"],"URL":"https:\/\/doi.org\/10.1007\/s12687-020-00468-2","relation":{},"ISSN":["1868-310X","1868-6001"],"issn-type":[{"value":"1868-310X","type":"print"},{"value":"1868-6001","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,28]]},"assertion":[{"value":"8 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. I Rafi has no declaration of interest.Dr. I Crinson has declared no conflicts of interest.Professor Dawes is founder and CSO of GenXys a medication decision support software company.D Rafi has declared no conflicts of interest.Professor Pirmohamed has no conflict of interest.Dr. Fiona Walter has no conflict of interest (TBC).MP is involved in research assessing polypharmacy against a pharmacogenomics gene panel in a secondary care trust.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All participants provided informed consent. Ethics approval was not necessary as this was service evaluation. There was no animal research.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement of informed consent\/human and animal rights and informed consent"}}]}}